Header

UZH-Logo

Maintenance Infos

Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter - still a dilemma?


Hegi, Monika E; Stupp, Roger (2015). Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter - still a dilemma? Neuro-Oncology, 17(11):1425-1427.

Statistics

Citations

Dimensions.ai Metrics
11 citations in Web of Science®
10 citations in Scopus®
13 citations in Microsoft Academic
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:November 2015
Deposited On:04 Feb 2016 09:31
Last Modified:14 Feb 2018 10:50
Publisher:Oxford University Press
ISSN:1522-8517
OA Status:Closed
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1093/neuonc/nov198
PubMed ID:26374690

Download

Full text not available from this repository.
View at publisher